The CFAR Flow Cytometry/FACS Core provides state-of-the-art technical and methodologic support and instrumentation in flow cytometric analysis/immunophenotyping and fluorescence activated cell sorting for AIDS investigators at AECOM and collaborating institutions. The FACS Core lab and personnel have nearly a decade of experience in flow cytometric immunophenotype analysis of AIDS patients, and has been a member of the NIAID/DAIDS Flow Cytometry Advisory Committee since 1988. The Core lab has been fully certified in immunophenotype analysis for ACTG specimen processing since the inception of the certification program, and currently serves as the Flow Cytometry lab for seven outside Pediatric ACTG sites in addition to AECOM Adult and Pediatric ACTG specimens. The Core lab also serves as a reference lab for the T-cell determination quality control program of the CDC. The Core lab carries out fluorochrome staining, analysis and sorting on a wide variety of research and clinical specimens, including peripheral blood, semen, bone marrow, mammalian cell lines, and isolated and primary cultures of cells from fetal tissue. In addition, the Core lab and its personnel are involved in collaborative efforts to develop flow cytometric procedures for the evaluation of cellular activation and proliferation, apart from immunophenotype analysis, as well as methodology for concurrent analysis of surface phenotype and intracellular HIV-1 p24. The CFAR Flow Cytometry-FACS Core provides access to quality-controlled analysis of single-dual, and triple-fluorochrome labelled specimens, and the highest quality instrumentation for both analysis and sorting. Because the CFAR Flow/FACS Core is housed within the Institutional P-3 Biohazard Facility, it also provides a unique resource for analysis/sorting of unfixed cells, which can only be carried out in a P-3 environment. The Flow Cytometry/FACS Core has demonstrated ability and capacity for efficiently handling a large and diverse research and clinical specimen load, as reflected in its support of numerous AECOM investigators as well as multiple ACTG sites. In addition, the broad range of experience and expertise of Core personnel in both research and clinical applications of Flow Cytometry. provides an effective foundation for promotion of interactive multidisciplinary collaborations.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI027741-06
Application #
3746987
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Rubinstein, Arye (2005) Preclinical studies of alkylureas as anti-HIV-1 contraceptive. Curr Pharm Des 11:3769-78
Lenz, J; Su, M; Mizrachi, Y et al. (2001) V3 variation in HIV-seropositive patients receiving a V3- targeted vaccine. AIDS 15:577-81
Browning Paul, J; Wang, E J; Pettoello-Mantovani, M et al. (2000) Mice transgenic for monocyte-tropic HIV type 1 produce infectious virus and display plasma viremia: a new in vivo system for studying the postintegration phase of HIV replication. AIDS Res Hum Retroviruses 16:481-92
Rubinstein, A; Mizrachi, Y; Bernstein, L et al. (2000) Progressive specific immune attrition after primary, secondary and tertiary immunizations with bacteriophage phi X174 in asymptomatic HIV-1 infected patients. AIDS 14:F55-62
Yurasov, S V; Pettoello-Mantovani, M; Raker, C A et al. (1999) HIV type 1 infection of human fetal bone marrow cells induces apoptotic changes in hematopoietic precursor cells and suppresses their in vitro differentiation and capacity to engraft SCID mice. AIDS Res Hum Retroviruses 15:1639-52
Rubinstein, A; Mizrachi, Y; Pettoello-Mantovani, M et al. (1999) Immunologic responses of HIV-1-infected study subjects to immunization with a mixture of peptide protein derivative-V3 loop peptide conjugates. J Acquir Immune Defic Syndr 22:467-76
Pettoello-Mantovani, M; Kollmann, T R; Katopodis, N F et al. (1998) thy/liv-SCID-hu mice: a system for investigating the in vivo effects of multidrug therapy on plasma viremia and human immunodeficiency virus replication in lymphoid tissues. J Infect Dis 177:337-46
Landor, M; Rubinstein, A; Kim, A et al. (1998) Receptor-mediated maternofetal transfer of immunoglobulins. Inhibition of transport of anti-HIV-1 immunoglobulin by generic immunoglobulins in the in vitro perfused placenta. Int Arch Allergy Immunol 115:203-9
Browning, J; Horner, J W; Pettoello-Mantovani, M et al. (1997) Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. Proc Natl Acad Sci U S A 94:14637-41
Harish, Z; Rubinstein, A; Golodner, M et al. (1997) Suppression of HIV-1 replication by propolis and its immunoregulatory effect. Drugs Exp Clin Res 23:89-96

Showing the most recent 10 out of 36 publications